Your Messages Inbox
Your Article Summary
See Latest ArticlesImmunoGen, Inc. Announces Completion of Public Offering of Common Stock
ImmunoGen, Inc., 06/24/09
ImmunoGen, Inc. , a biopharmaceutical company that develops targeted anticancer therapeutics, announced the completion of its previously reported public offering of 5,750,000 shares of common stock. The Company received net proceeds, after underwriting discounts and commissions and estimated expenses, of approximately $38.0 million.
Today in Research & Development...keeping you current
Receive free subspecialty "5-minute updates" via email
New Amgen Scholars Web site Launches to Build a Global Network for Future Scientists
Amgen, 12/04/09
Bayer Team wins the “Deutscher Zukunftspreis” awarded by the German President
BayNews International, 12/03/09
GSK Update: GSKs Arepanrix H1N1 pandemic vaccine prequalified by the World Health Organization
GlaxoSmithKline, 12/02/09
Article Search
Sponsor